Literature DB >> 15706465

Olanzapine-induced acute rhabdomyolysis-a case report.

U Baumgart, R Schmid, H Spiessl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15706465     DOI： 10.1055/s-2005-837770

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  5 in total

1.  Serum creatine kinase elevation as a possible complication of therapy with olanzapine.

Authors:  Evgeniy Perlov; Ludger Tebartz van Elst; Martin Czygan; Emanuel Bubl; Dieter Ebert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-22       Impact factor: 3.000

Review 2.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

3.  [Malignant neuroleptic syndrome associated with amisulpride].

Authors:  C Harter; C Obier; K-F Druschky; B Eikelmann
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

Review 4.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

5.  Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome with rhabdomyolysis: a case report.

Authors:  Young Kyoung Sa; Hyeon Yang; Hee Kyoung Jung; Jang Won Son; Seong Su Lee; Seong Rae Kim; Bong Yeon Cha; Ho Young Son; Chi-Un Pae; Soon Jib Yoo
Journal:  Endocrinol Metab (Seoul)       Date:  2013-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.